Fevronia Kiparissi
Overview
Explore the profile of Fevronia Kiparissi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pujol-Muncunill G, Navas-Lopez V, Ledder O, Cohen S, Lekar M, Turner D, et al.
Eur J Pediatr
. 2024 May;
183(8):3253-3262.
PMID: 38700692
Ustekinumab is an effective therapy for adult Crohn's disease (CD), but data in paediatric CD patients are scarce. The aim of the study was to describe the real-life effectiveness and...
2.
Hubbard R, Brooks A, Arebi N, El-Khouly S, Kiparissi F, Mozdiak E, et al.
Frontline Gastroenterol
. 2023 Oct;
14(6):491-496.
PMID: 37854783
Objective: To explore Young Persons (YP) and healthcare professionals (HCP) experiences of virtual consultations (VC) and establish whether developmentally appropriate healthcare can be delivered virtually. Method: YP and HCP questionnaire...
3.
Kiparissi F, Dastamani A, Palm L, Azabdaftari A, Campos L, Gaynor E, et al.
Hum Genet
. 2023 Feb;
142(5):697-704.
PMID: 36773065
Phosphomannomutase 2 (PMM2) deficiency causes Congenital Disorder of Glycosylation (PMM2-CDG), but does not have a recognised association with Inflammatory Bowel Disease (IBD). A distinct clinical syndrome of hyperinsulinism and autosomal...
4.
Cococcioni L, Pensabene L, Puoti M, El-Kouly S, Chadokufa S, Buckingham R, et al.
Clin Transl Gastroenterol
. 2023 Feb;
14(3):e00544.
PMID: 36729814
Introduction: Split-dose thiopurine and allopurinol-thiopurine cotherapy strategies have been suggested as rescue therapeutic options for children with inflammatory bowel disease (IBD) and impaired thiopurine metabolism. We compared the efficacy and...
5.
Yerushalmy-Feler A, Pujol-Muncunill G, Martin-de-Carpi J, Kolho K, Levine A, Olbjorn C, et al.
J Pediatr Gastroenterol Nutr
. 2022 Sep;
75(6):717-723.
PMID: 36084231
Objectives: Escalation of the ustekinumab (UST) maintenance dosage was effective in adults with Crohn disease (CD), but no data are available for children. We evaluated the effectiveness and safety of...
6.
Ashton J, Narula P, Kiparissi F, Spray C, Wilson D, Tayler R, et al.
J Pediatr Gastroenterol Nutr
. 2021 Apr;
73(2):251-258.
PMID: 33853108
Objectives: Patients with paediatric inflammatory bowel disease (IBD) constitute one of the largest cohorts requiring transition from paediatric to adult services. Standardised transition care improves short and long-term patient outcomes....
7.
Cococcioni L, Pensabene L, El-Khouly S, Chadokufa S, McCartney S, Saliakellis E, et al.
Dig Liver Dis
. 2021 Mar;
53(7):830-834.
PMID: 33775573
Background: Although intravenous ferric carboxymaltose (FCM) is effective in treating iron deficiency anemia (IDA) in paediatric inflammatory bowel disease (pIBD), no data are available on its post-infusion related risks. Aims:...
8.
Puoti M, Rybak A, Kiparissi F, Gaynor E, Borrelli O
Front Pediatr
. 2021 Mar;
9:617980.
PMID: 33692973
Coronavirus disease 2019 (COVID-19), caused by acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is predominantly a respiratory disease. However, its significant impact on the gastrointestinal (GI) system is now well-known. SARS-CoV-2...
9.
Lazaridis N, Murino A, Koukias N, Kiparissi F, Despott E
VideoGIE
. 2020 Sep;
5(9):412-414.
PMID: 32954102
No abstract available.
10.
Hansen R, Meade S, Beattie R, Auth M, Croft N, Davies P, et al.
Gut
. 2020 Sep;
70(6):1044-1052.
PMID: 32873696
Objective: Paediatric acute severe colitis (ASC) management during the novel SARS-CoV-2/COVID-19 pandemic is challenging due to reliance on immunosuppression and the potential for surgery. We aimed to provide COVID-19-specific guidance...